[HTML][HTML] The efficacy and safety of Anyu Peibo Capsule in the treatment of patients with major depressive disorder in China: study protocol for a randomized placebo …

J Huang, Y Yu, Y Jiang, W Chen, Y Li, Y Shen… - Trials, 2021 - Springer
Background Major depressive disorder is the second leading cause of years lost to disability
worldwide. Anyu Peibo Capsule has been shown to be effective and safe in phase II trials …

A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults

S He, Y Yu, J Huang, J Yin, Y Niu, Y Lu… - Therapeutic …, 2023 - journals.sagepub.com
Background: Almost one-third of patients with major depressive disorder (MDD) do not
respond to conventional antidepressants, and new treatments for MDD are urgently needed …

A randomized study on comparing effect and safety of wuling capsule and deanxit in patients with anxiety or depression status

L Shi, X Zhao, Y Wang, J Zhang… - Chinese Journal of …, 2009 - pesquisa.bvsalud.org
Objective To evaluate the efficacy and safety of wuling capsule compared with deanxit in
treatment of patients with depression or anxiety status. Methods A total of 139 patients with …

[HTML][HTML] Bangpungtongsung-san for patients with major depressive disorder: study protocol for a randomized controlled phase II clinical trial

Y Kim, Y Choi, MY Lee, SH Cho, IC Jung… - … Medicine and Therapies, 2023 - Springer
Background Bangpungtongsung-san (BTS) is a representative herbal medicine that has
been widely used for patients with obesity in east Asian countries. Various preclinical …

Jiawei Xiaoyao capsule treatment for mild to moderate major depression with anxiety symptoms: a randomized, double-blind, double-dummy, controlled, multicenter …

S Rui, F Jiping, L Tao, C Xindong… - Journal of …, 2019 - search.ebscohost.com
OBJECTIVE: To assess the efficacy and safety of Jiawei Xiaoyao (JWXY) capsules on mild
to moderate depression with anxiety symptoms, a randomized, double-blind, double-dummy …

Efficacy and safety of deanxit combined with wuling capsule in treating post-stroke depression: a randomized controlled trial

JL Fu, YW Zhao, XJ Sun - Zhong xi yi jie he xue bao= Journal of …, 2008 - europepmc.org
Objective To evaluate the safety and efficacy of Wuling Capsule combined with Deanxit in
treating post-stroke depression (PSD). Methods One hundred and fourteen patients with …

[PDF][PDF] Real-World Auvelity®(AXS-05) Patient Characteristics in Major Depressive Disorder

A Muzyk, FZ Syed, H Zhou, J Cong… - TeCA (mirtazapine … - axsomecongresshub.com
RESULTS Introduction METHODS Page 1 Real-World Auvelity® (AXS-05) Patient
Characteristics in Major Depressive Disorder Andrew Muzyk,1,2 Fatima Zahara Syed,3 …

[HTML][HTML] Notable efficacy of Shugan Jieyu capsule in treating adult with post-stroke depression: a PRISMA-compliant meta-analysis of randomized controlled trials

T Wu, T Yue, P Yang, Y Jia - Journal of Ethnopharmacology, 2022 - Elsevier
Ethnopharmacological relevance Post stroke depression (PSD), which happens in 40%–
60% stroke patients, is one of the most common complications after cerebrovascular …

Shuganjieyu capsule for major depressive disorder (MDD) in adults: a systematic review

X Zhang, D Kang, L Zhang, L Peng - Aging & mental health, 2014 - Taylor & Francis
Objectives: Shuganjieyu capsule is a pure herbal pharmaceutical product for depression.
Our objective was to explore the effectiveness and safety of Shuganjieyu capsule for the …

Meta-analysis of the efficacy and safety of Shugan Jieyu capsule in the treatment of senile depression.

Q Zou, Q Xu, Z Yang, Y Yuan, W Sun, B Wang - 2020 - cabidigitallibrary.org
Objective: To explore the efficacy and safety of Shugan Jieyu Capsule in the treatment of
senile depression by using the method of Meta analysis. Methods: Computer searched the …